NOVEL CRYSTAL FORMS OF OLANZAPINE, METHODS FOR THEIR PREPARATION AND METHOD FOR THE PREPARATION OF KNOWN OLANZAPINE CRYSTAL FORMS

Details for Australian Patent Application No. 2003300324 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES LTD.

Inventors DOLITZKY, Ben, Zion; ARONHIME, Judith; DILLER, Dov

Pub. Number AU-A-2003300324

PCT Number PCT/US2003/0411

PCT Pub. Number WO2004/058773

Priority 60/435,913 24.12.02 US

Filing date 24 December 2003

Wipo publication date 22 July 2004

International Classifications

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61P 025/18 Drugs for disorders of the nervous system

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/435,913 24.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-A-2003300324

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300325-WATER REPELLENT SURFACE TREATMENT AND TREATED ARTICLES

2003300323-VASCULAR PROSTHESIS AND METHODS OF USE